Bulk RNAseq of sample P12_Tumor_Post-treatment-Resistant
RNAseq was conducted on primary, responding, and resistant specimens using the Personalis NeXT Dx (TM) Tumor Profiling platform, which includes whole transcriptome sequencing.
NCI-PHS003970
P12_RNA_Post_Res_S21-17427-5B_tumor_rna